INVO Fertility (IVF) Gains from Sales and Divestitures (2019 - 2023)
INVO Fertility (IVF) reported Gains from Sales and Divestitures of $16505.0 for Q3 2023, down 87.91% year-over-year from $136507.0 in Q3 2022, and little changed on a QoQ basis from $16505.0 in Q2 2023.
INVO Fertility (IVF) has 5 years of Gains from Sales and Divestitures data on file, last reported at $16505.0 in Q3 2023.
- Quarterly Gains from Sales and Divestitures fell 87.91% year-over-year to $16505.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $16505.0 (down 87.91% YoY) and the FY2022 annual result came in at $143174.0, down 30.17% from the prior year.
- Gains from Sales and Divestitures was little changed at $16505.0 in Q3 2023 per IVF's latest filing, from $16505.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $1.2 million in Q1 2020 and bottomed at $2083.0 in Q4 2019.
- The 5-year median for Gains from Sales and Divestitures is $71312.5 (2020), against an average of $147945.1.
- The widest annual swing landed in 2020, when Gains from Sales and Divestitures soared 2973.5%; it then slumped 97.89% in 2021.
- Tracing IVF's Gains from Sales and Divestitures over 5 years: stood at $2083.0 in 2019, then soared by 2973.5% to $64021.0 in 2020, then jumped by 220.26% to $205031.0 in 2021, then tumbled by 30.17% to $143174.0 in 2022, then slumped by 88.47% to $16505.0 in 2023.
- Per Business Quant, the three latest IVF Gains from Sales and Divestitures figures stand at $16505.0 (Q3 2023), $16505.0 (Q2 2023), and $179798.0 (Q1 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 16,505.00 |
| Sep 30, 2023 | 16,505.00 |
| Jun 30, 2023 | 16,505.00 |
| Jun 30, 2023 | 16,505.00 |
| Mar 31, 2023 | 179,798.00 |
| Mar 31, 2023 | 179,798.00 |
| Dec 31, 2022 | 143,174.00 |
| Dec 31, 2022 | 143,174.00 |
| Sep 30, 2022 | 136,507.00 |
| Sep 30, 2022 | 136,507.00 |
| Jun 30, 2022 | 100,841.00 |
| Jun 30, 2022 | 100,841.00 |
| Mar 31, 2022 | 76,841.00 |
| Mar 31, 2022 | 76,841.00 |
| Dec 31, 2021 | 205,031.00 |
| Dec 31, 2021 | 205,031.00 |
| Sep 30, 2021 | 74,669.00 |
| Sep 30, 2021 | 74,669.00 |
| Jun 30, 2021 | 49,986.00 |
| Jun 30, 2021 | 49,986.00 |
| Mar 31, 2021 | 24,445.00 |
| Mar 31, 2021 | 24,445.00 |
| Dec 31, 2020 | 64,021.00 |
| Dec 31, 2020 | 64,021.00 |
| Sep 30, 2020 | 50,871.00 |
| Sep 30, 2020 | 50,871.00 |
| Jun 30, 2020 | 67,956.00 |
| Jun 30, 2020 | 67,956.00 |
| Mar 31, 2020 | 1.16 Mn |
| Mar 31, 2020 | 1.16 Mn |
| Dec 31, 2019 | 2,083.00 |
| Dec 31, 2019 | 2,083.00 |